Primary Diffuse Large B-Cell Lymphoma of the Bone: Bendamustine and Rituximab Are Able to Overcome Resistant Disease
SpringerPlus - Germany
doi 10.1186/2193-1801-3-342
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 7, 2014
Authors
Publisher
Springer Science and Business Media LLC